Bill would establish CISO role for HHS

House Energy and Commerce Committee members Congresswoman Doris Matsui (D-Calif.) and Congressman Billy Long (R-Mo.) introduced the HHS Data Protection Act, which would establish the Office of the Chief Information Security Officer (CISO) within the Department of Health and Human Services (HHS) and elevate the position out from under the CIO.

The legislation builds on the Obama Administration’s Cybersecurity National Action Plan, a comprehensive strategy for enhancing cybersecurity protections which recognizes the importance of a CISO in improving cybersecurity capabilities, according to a release. Earlier this year, the Administration created the position of the Federal Chief Information Security Officer, the first dedicated senior official in the Administration focused exclusively on coordinating cybersecurity operations across the entire federal domain.

“It is impossible to completely eradicate the threat of cyber-attacks, but the American people deserve to know that their sensitive information is being safeguarded with the utmost security,” said Congressman Long. “In light of recent data breaches across America’s federal agencies, we have the responsibility to root out vulnerabilities and maximize data protection to give them that peace of mind.” In August 2015, the majority staff of the Energy & Commerce Committee released a report on information security at FDA following a breach of its internal network. The report recommended that HHS separate the CISO from the CIO to ensure that information security is appropriately prioritized. Access the bill.
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.